Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
American Thoracic Society
2019
|